De novo EHMT2 variants cause an autosomal dominant EHMT2-related Kleefstra syndrome via loss of G9a methyltransferase activity

Fecha de publicación:

Autores de IIS La Fe

Participantes ajenos a IIS La Fe

  • Hnízda A.
  • Martinez-Delgado B.
  • Sanchez-Ponce D.
  • Alonso J.
  • Amiel J.
  • Attie-Bitach T.
  • Bada-Navarro A.
  • Baladron B.
  • Bermejo-Sanchez E.
  • Brinsa V.
  • Buková I.
  • Cazorla-Calleja R.
  • Cervenková S.
  • Chow S.
  • Dušek P.
  • Fedosieieva O.
  • Fernandez-Prieto M.
  • Ghosh S.
  • Gomez-Mariano G.
  • Gregorová A.
  • Hamilton M.J.
  • Hartmannová H.
  • Hernandez-SanMiguel E.
  • Herrero-Matesanz M.
  • Hodanová K.
  • Kádek A.
  • Kerkhof J.
  • Kleefstra T.
  • Lacombe D.
  • Levy M.A.
  • Lopez-Martin E.
  • Lyse R.
  • Man P.
  • Macnamara E.F.
  • McConkey H.
  • Melenovská P.
  • Mielu L.M.
  • Moore D.
  • Steiner Mrázová L.
  • Musilová K.
  • Neffeová K.
  • Nickl P.
  • Pajuelo Reguera D.
  • Pavlíková M.
  • Pavlovicová L.
  • Posada M.
  • Procházka J.
  • Pysanenko K.
  • Ramos del Saz S.
  • Rots D.
  • Rzasa J.
  • Sedlácek R.
  • Stránecký V.
  • Špoutil F.
  • Tedder M.L.
  • Thompson L.
  • Tifft C.J.
  • Tran Mau-Them F.
  • Trešlová H.
  • Vitobello A.
  • Hilton S.
  • Campbell C.
  • Banka S.
  • Jirák D.
  • Sadikovic B.
  • Sikora J.
  • Kmoch S.
  • Barrero M.J.
  • Nosková L.

Grupos

Abstract

EHMT1 and EHMT2 genes encode human euchromatin histone lysine methyltransferase 1 and 2 (EHMT1 alias GLP; EHMT2 alias G9a) that form heteromeric GLP/G9a complexes with essential roles in epigenetic regulation of gene expression. While EHMT1 haploinsufficiency has been established as the cause of Kleefstra syndrome 1, the pathogenesis of G9a dysfunction in human disease remains largely unknown. We identified seven de novo EHMT2 variants in patients with clinical presentation, episignatures, histone modifications and transcriptomic profiles similar to those of Kleefstra syndrome 1. In vitro studies reveal that these variants encode for structurally stable G9a proteins that are catalytically incompetent due to aberrant interactions either with histone H3 tail or with S-adenosylmethionine. Heterozygous mice carrying a patient-derived variant exhibit growth retardation, facial/skull dysmorphia and aberrant behavior. Here we report pathogenic EHMT2 variants that likely exert dominant-negative effect on GLP/G9a complexes and thus genocopy the EHMT1 haploinsufficiency via a distinct molecular mechanism, defining an autosomal dominant EHMT2-related Kleefstra syndrome. © The Author(s) 2026.

Datos de la publicación

ISSN/ISSNe:
2041-1723, 2041-1723

Nature Communications  NATURE PORTFOLIO

Tipo:
Article
Páginas:
-
PubMed:
42386776
Enlace a otro recurso:
www.scopus.com
Factor de Impacto:
4,846 SCImago ℠
Cuartil:
Q1 SCImago ℠

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • Animals; Chromosome Deletion; Chromosomes, Human, Pair 9; Craniofacial Abnormalities; Female; Hand Deformities, Congenital; Haploinsufficiency; Heart Defects, Congenital; Histocompatibility Antigens; Histone-Lysine N-Methyltransferase; Histones; Humans; Intellectual Disability; Kleefstra Syndrome; Male; Mice; ademetionine; G9a protein; histone; histone H3; methyltransferase; unclassified drug; EHMT1 protein, human; EHMT2 protein, human; G9a protein, mouse; GLP protein, mouse; histocompatibility antigen; histone lysine methyltransferase; disease treatment; gene expression; molecular analysis; pathogen; protein; rodent; animal experiment; animal model; Article; autosomal dominant inheritance; behavior disorder; catalysis; chemical interaction; clinical article; clinical feature; complex formation; controlled study; craniofacial malformation; dimerization; DNA methylation; EHMT1 gene; EHMT2 gene; enzyme activity; enzyme substrate; epigenetics; face dysmorphia; female; gait; gene; gene del

Cita

Compartir